Hazlett, Burt & Watson »

Moleculin Biotech shares owned by Hazlett, Burt & Watson

Quarter-by-quarter ownership of Moleculin Biotech shares owned by Hazlett, Burt & Watson from 13F filings

Historical chart of Hazlett, Burt & Watson investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Hazlett, Burt & Watson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Hazlett, Burt & Watson

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 67 0.00

More positions owned by Hazlett, Burt & Watson

Schwab Strategic Tr Us Dividend Eq (SCHD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Ishares Tr Select Divid Etf (DVY)
Ishares Tr Core Div Grwth (DGRO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Specialized Funds Div App Etf (VIG)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Vanguard World Inf Tech Etf (VGT)

View all positions for Hazlett, Burt & Watson

Top funds holding Moleculin Biotech

CVA Family Office

View all funds holding Moleculin Biotech